What do we know about toxoplasmosis?

Contemporary Ob-Gyn

Volumn 41, Issue 2, 1996, Pages 41-69

  Freij, Bishara J ^a,b   Sever, John L ^c,d  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WILLIAM BEAUMONT HOSPITAL   (United States)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^d CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 24044512631     PISSN: 00903159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. ACOG: Perinatal viral and parasitic infections. ACOG Technical Bulletin Number 177. Int J Gynecol Obstet 1993;42:300
2. Wong S-Y, Remington JS: Biology of Toxoplasma gondii. AIDS 1993;7:299
3. Sever JL, Ellenberg JH, Ley AC, et al: Toxoplasmosis: Maternal and pediatric findings In 23,000 pregnancies. Pediatrics 1988;82:181
4. Remington JS, McLeod R, Desmonts G: Toxoplasmosis, in Remington JS, Klein JO, (eds): Infectious Diseases of the Fetus and Newborn Infant. 4th ed., Philadelphia, Pa., WB Saunders, 1995, pp 140-267
5. Wong S-Y, Remington JS: Toxoplasmosis in pregnancy. Clin Infect Dis 1994;18:853
6. Guerina NG, Hsu H-W, Meissner HC, et al: Neonatal serologic screening and early treatment for congenital Toxoplasma gondii infection. N Engl J Med 1994;330:1858
7. Freij BJ, Sever JL: Toxoplasmosis. Pediatr Rev 1991;12:227
8. Wallace MR, Rossetti RJ, Olson PE: Cats and toxoplasmosis risk in HW-infected adults. JAMA 1993;269:76
9. Pereira LH, Staudt M, Tanner CE, et al: Exposure to Toxoplasma gondii and cat ownership in Nova Scotia. Pediatrics 1992;89:1169
10. Burg JL, Grover CM, Pouletty P, et al: Direct and sensitive detection of a pathogenic protozoan, Toxoplasma gondii, by polymerase chain reaction. J Clin Microbiol 1989;27:1787
11. van de Ven E, Melchers W, Galama J, et al: Identification of Toxoplasma gondii infections by Bl gene amplification. J Clin Microbiol 1991;29:2120
12. Guy EC, Joynson DHM: Potential of the polymerase chain reaction in the diagnosis of active Toxoplasma infection by detection of parasite in blood. J Infect Dis 1995;172:319
13. Bobic B, Sibalic D, Djurkovic-Djakovic O: High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary Toxoplasma infection: Case report. Gynecol Obstet Invest 1991;31:182
14. Bessieres MH, Roques C, Berrebi A, et al: IgA antibody response during acquired and congenital toxoplasmosis. J Clin Pathol 1992;45:605
15. Wong S-Y, Hajdu M-P, Ramirez R, et al: Role of specific immunoglobulin E in diagnosis of acute Toxoplasma infection and toxoplasmosis. J Clin Microbiol 1993; 31:2952
16. Daffos F, Forestier F, Capella-Pavlovsky M, et al: Prenatal management of 746 pregnancies at risk for congenital toxoplasmosis. N Engl J Med 1988;318:271
17. Holliman RE, Johnson JD, Constantine G, et al: Difficulties in the diagnosis of congenital toxoplasmosis by cordocentesis: Case report. Br J Obstet Gynaecol 1991;98:832
18. Decoster A, Darcy F, Caron A, et al: Anti-P30 IgA antibodies as prenatal markers of congenital Toxoplasma Infection. Clin Exp Immunol 1992;87:310
19. Cotty F, Descamps P, Body G, et al: Prenatal diagnosis of congenital toxoplasmosis: The role of Toxoplasma IgA antibodies in amniotic fluid. J Infect Dis 1995;171:1384
20. Hohlfeld P, Daffos F, Costa JM, et al: Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N Engl J Med 1994;331:695
21. Marty P, Bongain A, Rahal A, et al: Prenatal diagnosis of severe fetal toxoplasmosis as a result of toxoplasmic reactivation in an HIV-1 seropositive woman. Prenat Diagn 1994;14:414
22. Couvreur J, Desmonts G, Thulliez P: Prophylaxis of congenital toxoplasmosis: Effects of spiramycin on placental infection. J Antimicrob Chemother 1988;22(Suppl B):193
23. Schoondermark-Van de Ven E, Melchers W, Camps W, et al: Effectiveness of spiramycin for treatment of congenital Toxoplasma gondii infection in rhesus monkeys. Antimicrob Agents Chemother 1994;38:1930
24. McCabe RE, Oster S: Current recommendations and future prospects in the treatment of toxoplasmosis. Drugs 1989;38:973
25. Hohlfeld P, Daffos F, Thulliez P, et al: Fetal toxoplasmosis: Outcome of pegnancy and infant follow-up after in utero treatment. J Pediatr 1989;115:765
26. St Georgiev V: Management of toxoplasmosis. Drugs 1994;48:179
27. Foulon W, Naessens A, Derde MP: Evaluation of the possibilities for preventing congenital toxoplasmosis. Am J Perinatal 1994;II:57
28. Berrebi A, Kobuch WE, Bessieres MH, et al: Termination of pregnancy for maternal toxoplasmosis. Lancet 1994;344:36
29. de Jong PTVM: Ocular toxoplasmosis; Common and rare symptoms and signs. Int Ophthalmol 1989;13:391
30. Brezin AP, Kasner L, Thulliez P, et al: Ocular toxoplasmosis In the fetus: Immunohistochemistry analysis and DNA amplification. Retina 1994;14:19
31. Meenken C, Assies J, van Nieuwenhuizen O, et al: Long term ocular and neurological involvement in severe congenital toxoplasmosis. Br J Ophthalmol 1995;79:581
32. Decoster A, Slizewicz B, Simon J, et al: Platelia-Toxo IgA, a new kit for early diagnosis of congenital toxoplasmosis by detection of anti-P30 immunoglobulin A antibodies. J Clin Microbiol 1991;29:2291
33. Decoster A, Gontier P, Dehecq E, et al: Detection of anti-Toxoplasma immunoglobulin A antibodies by Platelia-Toxo IgA directed against P30 and by IMx Toxo IgA for diagnosis of acquired and congenital toxoplasmosis. J Clin Microbiol 1995;33:2206
34. McAuley J, Boyer KM, Patel D, et al: Early and longitudinal evaluations of treated infants and children and untreated historical patients with congenital toxoplasmosis: The Chicago Collaborative Treatment Trial. Clin Infect Dis 1994;18:38
35. Roizen N, Swisher CN, Stein MA, et al: Neurologic and developmental outcome in treated congenital toxoplasmosis. Pediatrics 1995;95:11
36. Koppe JG, Rothova A: Congenital toxoplasmosis: A long-term follow-up of 20 years. Int Ophthalmol 1989;13:387